WhitTier Trust Company’s Moderna MRNA Stock Holding History

WhitTier Trust Company’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.98K	Buy	61 +40	+190%	+$1.87K	﹤0.01%	1221
2025 Q4	$749	Hold	21	–	–	﹤0.01%	1230
2025 Q3	$598	Buy	+21	New	+$586	﹤0.01%	1232
2025 Q2	–	Sell	-5	Closed	-$141	–	1468
2025 Q1	$141	Buy	+5	New	+$177	﹤0.01%	1402
2024 Q4	–	Sell	-5	Closed	-$333	–	1387
2024 Q3	$333	Hold	5	–	–	﹤0.01%	1300
2024 Q2	$593	Hold	5	–	–	﹤0.01%	1226
2024 Q1	$532	Buy	5 +2	+67%	+$202	﹤0.01%	1183
2023 Q4	$298	Buy	+3	New	+$252	﹤0.01%	1184
2023 Q2	–	Sell	-3	Closed	-$460	–	1183
2023 Q1	$460	Sell	3 -54	-95%	-$8.91K	﹤0.01%	1135
2022 Q4	$10.2K	Buy	+57	New	+$9.32K	﹤0.01%	942

Other funds holding MRNA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return